Literature DB >> 21421069

Actinomyces graevenitzii bacteremia in a patient with alcoholic liver cirrhosis.

Sang Sun Hwang1, Soon Deok Park, In Ho Jang, Young Uh, Kap Jun Yoon, Hyo Youl Kim.   

Abstract

We report the first case of Actinomyces graevenitzii septicemia in a patient with alcoholic liver cirrhosis. It was identified as A. graevenitzii by morphologic and 16S rRNA sequencing. Even though A. graevenitzii is rarely associated with human infections, it should be considered as a potential causative agent of bacteremia.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21421069     DOI： 10.1016/j.anaerobe.2011.03.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  4 in total

Review 1.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Pseudo-outbreak of Actinomyces graevenitzii associated with bronchoscopy.

Authors:  David R Peaper; Nancy L Havill; Michael Aniskiewicz; Deborah Callan; Olivia Pop; Dana Towle; John M Boyce
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

3.  Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli.

Authors:  E Farfour; J Leto; M Barritault; C Barberis; J Meyer; B Dauphin; A-S Le Guern; A Leflèche; E Badell; N Guiso; A Leclercq; A Le Monnier; M Lecuit; V Rodriguez-Nava; E Bergeron; J Raymond; S Vimont; E Bille; E Carbonnelle; H Guet-Revillet; H Lécuyer; J-L Beretti; C Vay; P Berche; A Ferroni; X Nassif; O Join-Lambert
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

4.  Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting.

Authors:  Yang Liu; Guillaume Méric; Aki S Havulinna; Shu Mei Teo; Fredrik Åberg; Matti Ruuskanen; Jon Sanders; Qiyun Zhu; Anupriya Tripathi; Karin Verspoor; Susan Cheng; Mohit Jain; Pekka Jousilahti; Yoshiki Vázquez-Baeza; Rohit Loomba; Leo Lahti; Teemu Niiranen; Veikko Salomaa; Rob Knight; Michael Inouye
Journal:  Cell Metab       Date:  2022-03-29       Impact factor: 31.373
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.